E25Bio

About:

E25Bio specializes in the development of rapid diagnostic tests for epidemic fever viruses.

Top Investors: Khosla Ventures, Alumni Ventures, Bill & Melinda Gates Foundation, The Engine, Small Business Innovation Research

Description:

E25Bio specializes in the development of rapid diagnostic tests for epidemic fever viruses. It is dedicated to preventing severe downstream health outcomes with the use of mobile, fast, real-time reporting to create unprecedented large datasets to guide informed and timely responses for the control of disease spread. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Total Funding Amount:

$10.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)e25bio.com

Founders:

Bobby Brooke Herrera, Irene Bosch, Lee Gehrke

Number of Employees:

11-50

Last Funding Date:

2020-08-13

IPO Status:

Private

Industries: